obesity drug news today october 21 2025 glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Weight-Loss Drug Demonstration Begins

(2007) Insulin-Like Growth Factor-I, Regulating Aromatase Expression through Steroidogenic Factor 1, Supports Estrogen-Dependent Tumor Leydig Cell Proliferation Elisabetta Scarano, et al

Tesamorelin: Stabilized Full-Length GHRH Tesamorelin takes a different approach from sermorelin and CJC-1295: GHRH(1-44) sequence full-length native human GHRH, not just GHRH(1-29) N-terminal trans-3-hexenoic acid modification the key stabilization feature Half-life approximately 25-40 minutes stabilized vs native GHRH(1-44)'s ~7 minutes Pharmaceutical approval as Egrifta for HIV-associated lipodystrophy The trans-3-hexenoic acid modification at the N-terminus protects against the primary enzymatic degradation site for GHRH

Nutritional deficiencies in vegan runners: A comparison of actual versus recommended nutritional intake and dietary recommendations

doi: 10.1007/s11096-018-0654-4